Analysts expect revenue increase Novartis, huge dividend

Tomorrow the Swiss company Novartis will publish its past quarter results. For this year the company, based in Basel revenue will be around 52.25 billion CHF. This is according to the average of the analysts' estimates. This is slightly more than 2020's revenue of 49.9 billion CHF.

Historical revenues and results Novartis plus estimates 2020

The analysts expect for 2021 a net profit of 14.28 billion CHF. According to most of the analysts the company will have a profit per share for this book year of 6.34 CHF. With this the price/earnings-ratio is 12.72.

Huge dividend Novartis

Analysts expect a dividend of 3.27 CHF per share. The dividend yield is then 4.05 percent. The average dividend yield of the pharmaceutical companies is a low 1.39 percent.

Most recent target prices around 98 CHF

The most recent recommendations for the pharmaceutical company are from Sanford C. Bernstein & Co, Goldman Sachs and Deutsche Bank .

Based on the current number of shares Novartis 's market capitalization equals 182.67 billion CHF. The Novartis stock was the past 12 months quite volatile. Since last April the stock is 3 percent lower. This year the stock price moved between 70 and 89 CHF.

Historical stock prices Novartis

At 10.05 the stock trades 0.5 percent lower at 80.65 CHF.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.